Next Article in Journal
Previous Article in Journal
Cancers 2011, 3(3), 2888-2903; doi:10.3390/cancers3032888
Review

Nanotechnology-Based Detection and Targeted Therapy in Cancer: Nano-Bio Paradigms and Applications

1,2,*  and 1
Received: 4 May 2011; in revised form: 28 May 2011 / Accepted: 1 July 2011 / Published: 15 July 2011
View Full-Text   |   Download PDF [312 KB, uploaded 15 July 2011]   |   Browse Figures
Abstract: The application of nanotechnology to biomedicine, particularly in cancer diagnosis and treatment, promises to have a profound impact on healthcare. The exploitation of the unique properties of nano-sized particles for cancer therapeutics is most popularly known as nanomedicine. The goals of this review are to discuss the current state of nanomedicine in the field of cancer detection and the subsequent application of nanotechnology to treatment. Current cancer detection methods rely on the patient contacting their provider when they feel ill, or relying on non-specific screening methods, which unfortunately often result in cancers being detected only after it is too late for effective treatment. Cancer treatment paradigms mainly rely on whole body treatment with chemotherapy agents, exposing the patient to medications that non-specifically kill rapidly dividing cells, leading to debilitating side effects. In addition, the use of toxic organic solvents/excipients can hamper the further effectiveness of the anticancer drug. Nanomedicine has the potential to increase the specificity of treatment of cancer cells while leaving healthy cells intact through the use of novel nanoparticles. This review discusses the use of nanoparticles such as quantum dots, nanoshells, nanocrystals, nanocells, and dendrimers for the detection and treatment of cancer. Future directions and perspectives of this cutting-edge technology are also discussed.
Keywords: nanomedicine; nanoparticles; dendrimer; PLGA; quantum dots; oncology; site-directed delivery; early detection; therapy nanomedicine; nanoparticles; dendrimer; PLGA; quantum dots; oncology; site-directed delivery; early detection; therapy
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Mousa, S.A.; Bharali, D.J. Nanotechnology-Based Detection and Targeted Therapy in Cancer: Nano-Bio Paradigms and Applications. Cancers 2011, 3, 2888-2903.

AMA Style

Mousa SA, Bharali DJ. Nanotechnology-Based Detection and Targeted Therapy in Cancer: Nano-Bio Paradigms and Applications. Cancers. 2011; 3(3):2888-2903.

Chicago/Turabian Style

Mousa, Shaker A.; Bharali, Dhruba J. 2011. "Nanotechnology-Based Detection and Targeted Therapy in Cancer: Nano-Bio Paradigms and Applications." Cancers 3, no. 3: 2888-2903.



Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert